Pope EK - Search Results

1

Lack of potentiation of vincristine-induced neurotoxicity by VP-16-213.

Jackson DV Jr, Wells HB, White DR, Muss HB, Richards F 2nd, Cooper MR, Stuart JJ, Pope EK, Spurr CL. Jackson DV Jr, et al. Among authors: pope ek. Am J Clin Oncol. 1983 Jun;6(3):327-30. doi: 10.1097/00000421-198306000-00013. Am J Clin Oncol. 1983. PMID: 6303106 Clinical Trial.

2

Single agent vincristine by infusion in refractory multiple myeloma.

Jackson DV, Case LD, Pope EK, White DR, Spurr CL, Richards F 2nd, Stuart JJ, Muss HB, Cooper MR, Black WR, et al. Jackson DV, et al. Among authors: pope ek. J Clin Oncol. 1985 Nov;3(11):1508-12. doi: 10.1200/JCO.1985.3.11.1508. J Clin Oncol. 1985. PMID: 2997407

3

Phase II study of vincristine infusion in refractory small cell carcinoma of the lung.

Jackson DV Jr, Pope EK, Hire EA, Spurr CL, Rardin DA, McCulloch J. Jackson DV Jr, et al. Among authors: pope ek. Am J Clin Oncol. 1985 Apr;8(2):154-6. doi: 10.1097/00000421-198504000-00009. Am J Clin Oncol. 1985. PMID: 3010697

4

Clinical trial of pyridoxine to reduce vincristine neurotoxicity.

Jackson DV Jr, Pope EK, McMahan RA, Cooper MR, Atkins JN, Callahan RD, Paschold EH, Grimm RA, Hopkins JO, Muss HB, et al. Jackson DV Jr, et al. Among authors: pope ek. J Neurooncol. 1986;4(1):37-41. doi: 10.1007/BF02158000. J Neurooncol. 1986. PMID: 3528407 Clinical Trial.

5

Cytotoxic chemotherapy and androgen priming in patients with advanced carcinoma of the prostate. A phase II trial of the Piedmont Oncology Association.

Muss HB, Case D, Cooper MR, Richards F 2nd, Spurr CL, Resnick MI, Zekan P, Nelson EC, Puckett JB, Pope E, et al. Muss HB, et al. Am J Clin Oncol. 1985 Oct;8(5):396-400. doi: 10.1097/00000421-198510000-00011. Am J Clin Oncol. 1985. PMID: 4061374

6

Sequential hemibody irradiation integrated into a chemotherapy-local radiotherapy program for limited disease small cell lung cancer.

Powell BL, Jackson DV Jr, Scarantino CW, Pope EK, Case LD, Choplin R, Richards F 2nd, Muss HB, Craig JB, Cruz JM, et al. Powell BL, et al. Among authors: pope ek. Int J Radiat Oncol Biol Phys. 1986 Nov;12(11):1951-6. doi: 10.1016/0360-3016(86)90131-8. Int J Radiat Oncol Biol Phys. 1986. PMID: 3021692

7

Clinical trial of folinic acid to reduce vincristine neurotoxicity.

Jackson DV Jr, McMahan RA, Pope EK, Case LD, Cooper MR, Kaplon MK, Richards F 2nd, Stuart JJ, White DR, Zekan PJ. Jackson DV Jr, et al. Among authors: pope ek. Cancer Chemother Pharmacol. 1986;17(3):281-4. doi: 10.1007/BF00256700. Cancer Chemother Pharmacol. 1986. PMID: 3488849

8

Prospective evaluation of changes in computed cranial tomography in patients with small cell lung carcinoma treated with chemotherapy and prophylactic cranial irradiation.

Craig JB, Jackson DV, Moody D, Cruz JM, Pope EK, Powell BL, Spurr CL, Capizzi RL. Craig JB, et al. Among authors: pope ek. J Clin Oncol. 1984 Oct;2(10):1151-6. doi: 10.1200/JCO.1984.2.10.1151. J Clin Oncol. 1984. PMID: 6092552

9

Improved tolerance of vincristine by glutamic acid. A preliminary report.

Jackson DV Jr, Pope EK, Case LD, Wells HB, White DR, Cooper MR, Caldwell RD, Black WR, Muss HB, Cruz JM, et al. Jackson DV Jr, et al. Among authors: pope ek. J Neurooncol. 1984;2(3):219-22. doi: 10.1007/BF00253273. J Neurooncol. 1984. PMID: 6150069

10

Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: a preliminary analysis.

Powell BL, Jackson DV Jr, Scarantino CW, Pope E, Choplin R, Craig JB, Atkins JN, Cooper MR, Hopkins JO, McMahan R, et al. Powell BL, et al. Int J Radiat Oncol Biol Phys. 1985 Mar;11(3):457-62. doi: 10.1016/0360-3016(85)90175-0. Int J Radiat Oncol Biol Phys. 1985. PMID: 2982771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page